HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Contribution of gadolinium DOTA in primary tumors of bone and soft tissue].

Abstract
20 patients with a primary musculo skeletal tumor were investigated by MRI to assess the efficacy of Gd DOTA. The essential contribution is that it distinguishes the active parts of the lesion, intratumoral necrosis or sequelae cavities that do not take up the contrast medium. The injection does not allow for differentiation between tumor recurrence and treatment-induced inflammatory abnormality.
AuthorsD Vanel, C Coffre, G Contesso, D Sarrazin, J Masselot
JournalJournal de radiologie (J Radiol) Vol. 69 Issue 12 Pg. 735-9 (Dec 1988) ISSN: 0221-0363 [Print] France
Vernacular TitleApport du gadolinium DOTA dans 20 tumeurs primitives des os et des parties molles.
PMID3246681 (Publication Type: Journal Article)
Chemical References
  • Heterocyclic Compounds
  • Organometallic Compounds
  • gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate
  • Gadolinium
Topics
  • Adult
  • Aged
  • Bone Neoplasms (diagnosis)
  • Evaluation Studies as Topic
  • Female
  • Gadolinium
  • Heterocyclic Compounds
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Organometallic Compounds
  • Soft Tissue Neoplasms (diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: